Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maninder Sandey

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Scientific Reports|October 22, 2021
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patientsJonathan Marable, Damien Ruiz, Anil K Jaiswal, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2026
Oncolytic virus with an immune stimulatory payload for osteosarcoma therapySumbul Khan, Theresa A Higgins, Isabella Shimko-Lofano, et al.
Research Square|May 18, 2026
Immune modulatory oncolytic virus for osteosarcoma therapySumbul Khan, Theresa A Higgins, Isabella Shimko-Lofano, et al.
Iscience|October 11, 2022
Development of OX40 agonists for canine cancer immunotherapyDamien Ruiz, Chloe Haynes, Jonathan Marable, et al.
Genes|April 23, 2022
Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression StudiesRebecca L Nance, Sara J Cooper, Dmytro Starenki, et al.
Heliyon|February 22, 2021
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patientsPayal Agarwal, Elizabeth A Gammon, Maninder Sandey, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Intravenous gene therapy improves lifespan and clinical outcomes in feline Sandhoff DiseaseAnne S Maguire, Linh Ta, Amanda L Gross, et al.
Natural Product Communications|July 26, 2021
<i>Oroxylum indicum</i> extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Liver Research|December 13, 2021
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Scientific Reports|October 22, 2021
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patientsJonathan Marable, Damien Ruiz, Anil K Jaiswal, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2026
Oncolytic virus with an immune stimulatory payload for osteosarcoma therapySumbul Khan, Theresa A Higgins, Isabella Shimko-Lofano, et al.
Research Square|May 18, 2026
Immune modulatory oncolytic virus for osteosarcoma therapySumbul Khan, Theresa A Higgins, Isabella Shimko-Lofano, et al.
Iscience|October 11, 2022
Development of OX40 agonists for canine cancer immunotherapyDamien Ruiz, Chloe Haynes, Jonathan Marable, et al.
Genes|April 23, 2022
Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression StudiesRebecca L Nance, Sara J Cooper, Dmytro Starenki, et al.
Heliyon|February 22, 2021
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patientsPayal Agarwal, Elizabeth A Gammon, Maninder Sandey, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Intravenous gene therapy improves lifespan and clinical outcomes in feline Sandhoff DiseaseAnne S Maguire, Linh Ta, Amanda L Gross, et al.
Natural Product Communications|July 26, 2021
<i>Oroxylum indicum</i> extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Liver Research|December 13, 2021
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J miceSatyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, et al.
Pageof 4